Net Income Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual net income in 2023 was 5.87 Billion HKD , down -3.58% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly net income in 2024 Q2 was 3.24 Billion HKD , down 0.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported an annual net income of 6.09 Billion HKD in 2022, up 8.67% from previous year.
CSPC Pharmaceutical Group Limited reported an annual net income of 5.6 Billion HKD in 2021, up 8.63% from previous year.
CSPC Pharmaceutical Group Limited reported a quarterly net income of 3.13 Billion HKD for 2023 Q4, up 105.53% from previous quarter.
CSPC Pharmaceutical Group Limited reported a quarterly net income of 1.52 Billion CNY for 2023 Q3, down -0.68% from previous quarter.

Annual Net Income Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Net Income of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year	Net Income	Net Income Growth
2023	5.87 Billion HKD	-3.58%
2022	6.09 Billion HKD	8.67%
2021	5.6 Billion HKD	8.63%
2020	5.15 Billion HKD	22.51%
2019	4.21 Billion HKD	31.2%
2018	3.21 Billion HKD	38.66%
2017	2.31 Billion HKD	23.07%
2016	1.88 Billion HKD	34.9%
2015	1.39 Billion HKD	37.48%
2014	1.01 Billion HKD	33.44%
2013	760.11 Million HKD	-56.34%
2012	1.74 Billion HKD	822.62%
2011	188.7 Million HKD	-70.54%
2010	640.6 Million HKD	-25.05%
2009	854.68 Million HKD	3.2%
2008	828.16 Million HKD	85.42%
2007	446.64 Million HKD	2799.45%
2006	15.4 Million HKD	-90.53%
2005	162.69 Million HKD	-37.58%
2004	260.62 Million HKD	-51.38%
2003	536.07 Million HKD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	3.24 Billion HKD	0.0%
2023 Q4	3.13 Billion HKD	105.53%
2023 Q3	1.52 Billion CNY	-0.68%
2023 FY	5.87 Billion HKD	-3.58%
2023 Q2	1.53 Billion CNY	7.65%
2023 Q1	1.42 Billion HKD	-59.25%
2022 Q4	3.5 Billion HKD	0.0%
2022 FY	6.09 Billion HKD	8.67%
2022 Q2	3.58 Billion HKD	0.0%
2021 Q2	3.67 Billion HKD	0.0%
2021 FY	5.6 Billion HKD	8.63%
2021 Q4	3.07 Billion HKD	0.0%
2020 Q2	2.55 Billion HKD	0.0%
2020 Q4	3.25 Billion HKD	0.0%
2020 FY	5.15 Billion HKD	22.51%
2019 FY	4.21 Billion HKD	31.2%
2019 Q4	2.04 Billion HKD	0.0%
2019 Q2	2.17 Billion HKD	0.0%
2018 Q1	796.71 Million HKD	0.0%
2018 Q2	796.71 Million HKD	0.0%
2018 Q3	869.26 Million HKD	9.11%
2018 Q4	933.33 Million HKD	7.37%
2018 FY	3.21 Billion HKD	38.66%
2017 FY	2.31 Billion HKD	23.07%
2017 Q4	796.71 Million HKD	9.02%
2017 Q3	730.77 Million HKD	25.83%
2017 Q2	580.75 Million HKD	0.0%
2017 Q1	580.75 Million HKD	0.0%
2016 FY	1.88 Billion HKD	34.9%
2016 Q4	580.75 Million HKD	8.56%
2016 Q3	534.94 Million HKD	13.08%
2016 Q2	473.04 Million HKD	0.0%
2016 Q1	473.04 Million HKD	0.0%
2015 Q3	351.62 Million HKD	0.0%
2015 FY	1.39 Billion HKD	37.48%
2015 Q1	351.62 Million HKD	0.0%
2015 Q4	473.04 Million HKD	34.53%
2015 Q2	351.62 Million HKD	0.0%
2014 Q3	256.75 Million HKD	0.0%
2014 FY	1.01 Billion HKD	33.44%
2014 Q2	256.75 Million HKD	0.0%
2014 Q1	256.75 Million HKD	0.0%
2014 Q4	351.62 Million HKD	36.95%
2013 Q3	193.26 Million HKD	0.0%
2013 Q4	256.75 Million HKD	32.85%
2013 Q2	193.26 Million HKD	0.0%
2013 Q1	193.26 Million HKD	0.0%
2013 FY	760.11 Million HKD	-56.34%
2012 Q4	193.26 Million HKD	-55.73%
2012 Q3	436.58 Million HKD	0.0%
2012 Q1	436.58 Million HKD	0.0%
2012 FY	1.74 Billion HKD	822.62%
2012 Q2	436.58 Million HKD	0.0%
2011 Q4	436.58 Million HKD	761.56%
2011 Q1	50.67 Million HKD	0.0%
2011 Q2	50.67 Million HKD	0.0%
2011 Q3	50.67 Million HKD	0.0%
2011 FY	188.7 Million HKD	-70.54%
2010 Q3	165.07 Million HKD	0.0%
2010 FY	640.6 Million HKD	-25.05%
2010 Q2	165.07 Million HKD	0.0%
2010 Q1	165.07 Million HKD	0.0%
2010 Q4	50.67 Million HKD	-69.3%
2009 Q3	216.37 Million HKD	0.0%
2009 Q4	165.07 Million HKD	-23.71%
2009 FY	854.68 Million HKD	3.2%
2009 Q1	216.37 Million HKD	0.0%
2009 Q2	216.37 Million HKD	0.0%
2008 Q4	216.37 Million HKD	3.8%
2008 Q3	208.46 Million HKD	0.0%
2008 Q2	208.46 Million HKD	0.0%
2008 Q1	208.46 Million HKD	0.0%
2008 FY	828.16 Million HKD	85.42%
2007 FY	446.64 Million HKD	2799.45%
2007 Q1	111.66 Million HKD	0.0%
2007 Q3	111.66 Million HKD	0.0%
2007 Q2	111.66 Million HKD	0.0%
2007 Q4	208.46 Million HKD	86.7%
2006 Q3	3.85 Million HKD	0.0%
2006 Q4	111.66 Million HKD	2799.45%
2006 FY	15.4 Million HKD	-90.53%
2006 Q1	3.85 Million HKD	0.0%
2006 Q2	3.85 Million HKD	0.0%
2005 Q4	3.85 Million HKD	-90.53%
2005 FY	162.69 Million HKD	-37.58%
2005 Q3	40.67 Million HKD	0.0%
2005 Q1	40.67 Million HKD	0.0%
2005 Q2	40.67 Million HKD	0.0%
2004 Q4	40.67 Million HKD	-37.77%
2004 Q1	65.36 Million HKD	0.0%
2004 Q3	65.36 Million HKD	0.0%
2004 Q2	65.36 Million HKD	0.0%
2004 FY	260.62 Million HKD	-51.38%
2003 Q3	134.76 Million HKD	0.0%
2003 Q2	134.76 Million HKD	0.0%
2003 Q1	134.76 Million HKD	0.0%
2003 FY	536.07 Million HKD	0.0%
2003 Q4	65.36 Million HKD	-51.5%
2002 Q4	134.76 Million HKD	0.0%

Peer Net Income Comparison of CSPC Pharmaceutical Group Limited

Name	Net Income	Net Income Difference

Global Stocks Search

CSPC Pharmaceutical Group Limited (1093.HK)

Net Income Summary of CSPC Pharmaceutical Group Limited

Annual Net Income Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Net Income of CSPC Pharmaceutical Group Limited (2023 - 2003)

Peer Net Income Comparison of CSPC Pharmaceutical Group Limited